AstraZeneca CFO quits for Goldman

Jon Symonds, chief financial officer of AstraZeneca, is leaving the pharmaceutical group to join Goldman Sachs, as the bank looks to capitalise on his high-level influence at UK companies.

ByJames Taylor

4 January 2013•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

North America

AstraZeneca CFO quits for Goldman

Goldman Sachs

Related articles